More than 100 000 women older than 70 years are diagnosed with hormone receptor-positive, early-stage breast cancer each year in the USA.1 A large proportion are at low risk of disease recurrence, ...

While speaking on her podcast Tea Time with Raven & Miranda, which she co-hosts with wife Miranda Pearman-Maday, the Disney ...

Raven-Symoné recalled having her first breast reduction when she was just 15 years old. While speaking on her podcast Tea ...

Raven-Symoné recalls being pushed to alter her body in order to get a television show at the tender age of 15.

While under competitive pressure from Novartis and Eli Lilly, Pfizer can tally up a unique trial win for its Ibrance in a ...

The benefit of the PARP inhibitor in patients with germline BRCA pathogenic variants remains evident 10 years after the first ...

The Institute of Cancer Research believes that animal research is essential to understand how cancers develop within a whole organism, and how to treat it.

The findings from the study demonstrated a substantial decrease in reoperation rates when the Histolog scanner was utilised.

AstraZeneca and MSD's PARP inhibitor Lynparza has improved long-term survival when given as adjuvant therapy for early breast ...

The European Medicines Agency (EMA) will allow Novo Nordisk to add risk reduction for events related to kidney disease to the label of its diabetes drug Ozempic, the Danish drugmaker said in a ...

Biovica signed an agreement with US Biotech company in clinical phase Biovica received a significant order for TKa testing services Biovica published the outcome of exercise of warrants from series ...

The median time from breast cancer diagnosis to surgery was 0.8 years for risk-reducing mastectomies and three years for risk ...